Legislative and regulatory modernization for therapeutic products

Area of Science:

• Health Sciences
• Regulatory Affairs
• Public Health Policy

Background:

• The Canadian regulatory system for health products requires modernization.
• Integrating scientific and clinical expertise is crucial for regulatory assessment.

Purpose of the Study:

• To outline the incorporation of scientific and healthcare professional work into Canadian therapeutic product regulation.
• To present a modernized, lifecycle approach to health product regulation.
• To review legislative changes and international collaboration.

Main Methods:

• Review of the current Canadian regulatory system for health products.
• Presentation of a "lifecycle approach" to regulation.
• Examination of the Food and Consumer Safety Action Plan and Bill C-51.
• Analysis of challenges and opportunities for Canadian and international regulators.

Main Results:

• The current regulatory system is being modernized.
• A lifecycle approach enhances regulatory oversight.
• Legislative amendments and international cooperation are key components.

Conclusions:

• Modernizing Canada's health product regulatory system is essential.
• A lifecycle approach and legislative reform support informed decision-making.
• Collaboration with international regulators presents opportunities for improvement.